News

Amgen Inc. stock outperforms competitors on strong trading day
Shares of Amgen Inc. AMGN rose 1.15% to $272.41 Friday, on what proved to be an all-around positive trading session for the ...
BioPharma Dive2d
Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff
A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and ...
Read the Verdict: Federal Jury Finds Amgen Liable in Drug Monopolization Case
The jury after just over half a day of deliberations found Amgen Inc. liable on 10 of the 11 claims in the complaint, including monopolization and unreasonable restraint of trade in violation of the ...